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Abstract: The alkylating ability of the oxetane ring in the carbohydrate struc-
ture was investigated and a flexible method for the construction of a bolaform 
amphiplile skeleton with xylose as the polar head is proposed. The method is 
based on oxetane ring opening in the easily accessible 3,5-anhydro-1,2-O-cyc-
lohexylidenexylofuranose (1). One-step nitrogen alkylation in terminal diam-
ines with 1 gave the basic cationic bolaform skeleton with xylose as potential 
polar head and a deliberately chosen length of the non-polar spacer. Under 
similar experimental conditions, but with an appropriate mole ratio of the 
alkylating agent, the alkylation reaction provide for selective monoalkylation 
of the diamines. Successful alkylation in the xanthine series (theophylline) was 
also achieved with 1, giving a new 5-deoxy-5-(1,2,3,6-tetrahydro-1,3-dimethyl- 
-2,6-dioxo-7H-purin-7-yl)-α-D-xylofuranose derivative. 
Keywords: bolaform skeleton; oxetane ring; alkylation; ring opening. 
INTRODUCTION 
Oxiranes and oxetanes, as highly strained heterocycles, are archetypical alk-
ylating agents. Oxetanes are widely used in organic syntheses and are considered 
to be less carcinogenic and lack genotoxic capacity compared to epoxides and 
β-lactones.1 The alkylating potential of the oxetane ring is a consequence of its 
ring strain, which was determined to be 106 kJ mol–1, a value close to that of oxi-
rane (112 kJ mol–1).2 However, the ring-opening reactions of oxetanes usually 
require powerful acid catalysts, or other specific catalysts providing for particular 
synthetic features.3 The oxetane ring is for steric reasons rarely encountered in 
carbohydrates. When present, it frequently possesses interesting pharmaceutical 
properties and offers numerous possibilities for chemical transformations.4 In 
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this report, the high alkylation potential of the oxetane ring in the easily access-
ible 3,5-anhydro-1,2-O-cyclohexylidene-α-D-xylofuranose5 (1) toward the nitro-































Scheme 1. Alkylation ability of 3,5-anhydro-1,2-O-cyclohexylidene-α-D-xylofuranose (1). Its 
use for basic bolaform skeleton synthesis (2–4, the graphical curve represent the hydrophobic 
spacer), selective monoalkylation of diamines (5–8), and alkylation in the xanthine series 9. 
From the practical standpoint, the alkylation of aliphatic diamines leads to 
one-step construction of basic cationic bolaform detergent skeleton, while in the 
xanthine series, a new type of 7-xylose substituted theophylline derivative was 
obtained under mild and operationally simple reaction conditions. All alkylations 
were performed under solvent-free reaction conditions, additionally illustrating 
alkylation potential of the carbohydrate oxetane ring.  
EXPERIMENTAL 
Thermal solid-state alkylation reactions are classical examples among solvent-free reac-
tions, and not a new concept. In particular, the N-alkylation of phthalimides and heterocyclic 
systems, such as carbazole with alkyl halides, are known examples.6 Unexpectedly, the high 
inclination of the oxetane structure in 1 toward nitrogen alkylation in this investigation enabled 
the realization of solvent-free reactions, giving benefits in product isolation procedures. 
General reaction conditions. 1 and a diamine (1,2-diaminoethane, 1,4-diaminobutane, 
piperazine, N-methylpiperazine or theophylline from commercial suppliers and without 
further purification) were mixed in the appropriate mole ratio for alkylation of both nitrogen 
atoms, or selective alkylation of a single nitrogen in diamine compounds, with addition of 
water as catalyst. The reaction mixture was held in a hermetically sealed stainless steel reac-
tion flask at temperature 110–130 °C for 12 h with occasional mixing. The products were 
isolated either as free bases, hydrochloride or oxalate salts (Table I).  
Detailed experimental synthetic procedures and analytical data confirming the structures 
of the newly synthesized compounds are given in Supplementary material to this paper. 
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TABLE I. Products of alkylation of diamines and alkylation in xanthine series with a 
carbohydrate oxetane ring 





4 –N(CH2CH2)2N– 5,5′-(1,4-Piperazinediyl)bis[1,2-O-cyclohexylidene- 
-5-deoxy-α-D-xylofuranose] 
5 H2NCH2CH2NH– 5-((2-Aminoethyl)amino)-1,2-O-cyclohexylidene-5- 
-deoxy-α-D-xylofuranose dioxalate 
6 H2NCH2(CH2)2CH2NH– 5-((4-Aminobutyl)amino)-1,2-O-cyclohexylidene- 
-5-deoxy-α-D-xylofuranose dioxalate 














RESULTS AND DISCUSSION 
Amphiphiles with two polar heads connected by a hydrophobic spacer (bola-
amphiphiles) have attracted ever-increasing attention since similar structures 
were found in some archaebacteria cell membranes that sustain harsh environ-
ments, high salt concentrations and elevated ambient temperatures.7 A range of 
bolaamphiphiles have been synthesized so far, either to imitate components of a 
natural cell structure, or to investigate their lipophilic–hydrophilic properties.8 In 
attempts to realize specific properties, a variety of bolaform surfactants with a 
carbohydrate as the hydrophilic moiety have also been considered. Carbohydrate-
based detergents are recognized, and convenient syntheses of compounds with 
variable lipophilic–hydrophilic balance based on xylose, in particular, as the 
polar head, or from other carbohydrate but with preserved xylo-configuration, are 
known.9 Specifically, syntheses of bolaamphiphiles based on xylose are also 
described.10 The authors affirmed earlier findings11 on the significant impact of 
the length of the hydrophobic linkage (spacer) on the aggregation properties of 
bolaamphiphiles with sugar heads. Consequently, a simple synthetic method for 
the construction of the basic bolaform skeleton with xylose-based hydrophilic 
heads and deliberately preferred hydrophobic spacer length is intriguing. Herein, 
the alkylation ability of the oxetane ring in 1 toward terminal diamino com-
pounds as a simple, practical and flexible method for the construction of the 
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cationic bolaform skeleton, or selective monoalkylation of aliphatic diamines and 
natural products are reported. 
The opening of oxetane ring in 3,5-anhydro-derivatives of suitably pro-
tected12 xylofuranose derivatives with aqueous ammonia13 and amines14 was 
investigated earlier. The reaction leads to one-step nitrogen alkylation. Under 
simple reaction conditions, the one-step dialkylation of α,ω-diamines of the gen-
eral formula H2N–(CH2)n–NH2, or cyclic diamines (piperazine) with 1 lead 
smoothly to the basic bolaform skeleton 2–4. 
For further demonstration of akylating ability of carbohydrate oxetane 1, the 
alkylation of diamines accomplished under essentially the same experimental 
conditions but with a different mole ratio of 1 toward the diamines resulted in 
selective monoalkylation of diamines 5–8.  
Frequently, prior activation of oxirane and oxetane rings is a necessary step 
in alkylation reactions and different catalysts are used for this purpose. Proton-
ation of oxygen in oxetane ring significantly eases nucleophillic attack of nucleo-
phillic species present and hence, the ring opening is facilitated by acids. As 
demonstrated earlier, water could also play the role of the catalyst,15 and the 
present experiments afforded further experimental evidence on the subject. Parti-
cularly, water was found to be an appropriate catalyst for the alkylation tendency 
of 1, owing to the expected significant strain energy release in the system of three 
condensed small rings in 1.  
Our previous investigations of the reactivity of the 3,5-anhydro ring in 1 
towards selected nucleophiles demonstrated pronounced regioselectivity of the 
oxetane ring-opening process.16 Again, it was found to be the case in the reaction 
of 1 with diamines. The only isolable products originated from the regioselective 
nucleophillic attack of nitrogen on the terminal carbon atom of xylofuranose 
(C-5). No detectable products of inversion at the C-3 carbon of starting 1 were 
found because of the hypothetic nucleophilic attack at C-3, i.e., the xylo- con-
figuration was preserved throughout.  
To prove further the alkylating ability of the oxetane ring in the carbohydrate 
structure 1, the alkylation of some natural products was considered. Many nitro-
gen-containing heterocycles demonstrate pronounced pharmaceutical activity. 
Among them, xanthine and substituted xanthine derivatives are an important 
class of compounds with a well-known spectrum of activity.17 In particular, theo-
phylline pentosides are the subject of intensive synthetic interest because of their 
structural resemblance to nucleosides. Theophylline-7-riboside was evaluated as 
a partial agonist for ubiquitous adenosine receptors18 with the conclusion that it 
has characteristics between full agonists and full antagonists (xanthines). Fol-
lowing thee findings, further attempts were made to synthesize different 7-sub-
stituted xanthine derivatives with a modified ribose rest.19 To the best of our 
knowledge, among other theophylline 7-pentofuranosides, arabinoside and xylo-
side are also known.20 
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In further experiments, it was found that alkylating potential of the oxetane 
ring in 1 could be used for the facile synthesis of a 7-xylose substituted theo-
phylline derivative, however with a new pentose substitution pattern. Namely, all 
previously synthesized pentose derivatives were connected to theophylline 
through C1 xylose carbon.  
Thus, the alkylation of theophylline with 1 smoothly gave 5-deoxy-5- 
-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)-α-D-xylofuranose 
derivative 9. However, theophylline did not react under the standard procedure 
(heating a mixture of diamine, oxetane 1 and water as catalyst), but further 
activation of the 7′-theophylline position was necessary, and hence the potassium 
salt of theophylline was prepared.21 
CONCLUSIONS 
The use of protected 3,5-anhydroxylofuranose as alkylating agent represent a 
new practical and adaptive method to reach the basic cationic bolaform skeleton 
with xylose-based polar heads and variable lengths of non polar spacer. The 
described one-step synthetic procedure give products that could be easily con-
verted into carbohydrate polar heads with retained xylo-configuration, with deli-
berately chosen hydrophobic spacer length and in acceptable isolated yields. In 
the xanthine series, the alkylation provide for new 7-xylose substituted theo-
phylline with the substitution pattern reversed to that previously described. 
SUPPLEMENTARY MATERIAL 
Description of specific synthesis methods and the analytical and spectral data of the 
synthesized compounds are available electronically from http://www.shd.org.rs/JSCS/, or 
from the corresponding author on request.  
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АЛКИЛУЈУЋИ ПОТЕНЦИЈАЛ УГЉЕНОХИДРАТНИХ ОКСЕТАНА: ПРАКТИЧНА 
СИНТЕЗА ДЕРИВАТА БОЛАФОРМНОГ СКЕЛЕТА  
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Истражена је алкилујућа способност оксетанског прстена у структури угљених 
хидрата и предложена је флексибилна метода за синтезу скелета болаформних амфи-
фила са ксилозом као поларном главом. Метода је заснована на реакцији отварања 
оксетанског прстена код лако достуне 3,5-анхидро-1,2-О-циклохексилиден ксилофура-
нозе (1). Алкиловање на атому азота код терминалних диамина са 1 даје основни бола-
формни скелет са заштићенoм ксилозом као потенцијалном хидрофилном главом и по 
вољи изабраном дужином хидрофобног тела. У сличним реакционим условима, али са 
другачијим одговарајућим молским односом алкилујућег агенса, остварено је селек-
тивно моноалкиловање диамина. Такође, остварено је успешно алкиловање у структури 
ксантина, при чему је добијен раније неописани дериват ксантина 1,2-О-циклохекси-
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лиден-5-деокси-5-(1,2,3,6-тетрахидро-1,3-диметил-2,6-диоксо-7H-пурин-7-ил)-α-D-кси-
лофураноза. 
(Примљено 24. фебруара, ревидирано 30. марта, прихваћено 16. априла 2015) 
REFERENCES 
1. а) R. Gómez-Bombarelli, B. B. Palma, C. Martins, M. Kranendonk, A. S. Rodrigues, E. 
Calle, J. Rueff, J. Casado, Chem. Res. Toxicol. 23 (2010) 1275; b) R. G. Bombarelli, PhD 
Thesis, Universidad de Salamanca, Spain, 2011 
2. a) B. Rigner, S. Sunner, H. Watanabe, Acta Chem. Scand. 25 (1971) 141; b) S. W. 
Benson, C. R. Vickshank, D. M. Golden, G. R. Haugen, H. E. O’Neal, A. S. Rodgers, R. 
Shaw, R. Walsh, Chem. Rev. 69 (1969) 279 
3. a) Z. Wang, Z. Chen, J. Sun, Org. Biomol. Chem.12 (2014) 6028; b) A. Harrane, N. Naar, 
M. Belbachir, Mater. Lett. 61 (2007) 3555; c) B. Guo, J. T. Njardarson, Chem. Commun. 
49 (2013) 10802; d) R. N. Loy, E. N. Jacobsen, J. Am. Chem. Soc. 131 (2009) 2786 
4. F. Ç. Telli, K. Ay, G. Murat, G. Kök, Y. Salman, Med. Chem. Res. 22 (2013) 2253 
5. M. Kawana, H. Kuzuhara, S. Emoto, Bull. Chem. Soc. Jpn. 54 (1981) 1492 
6. a) D. Bogdal, J. Pielichowsky, A. Boron, Synlett. (1996) 873; b) D. Bogdal, J. 
Pielichowsky, K. Jascot, Synth. Commun. 45 (1997) 715 
7. a) G. H. Escamilla, G. R. Newkome, Angew. Chem. Int. Ed. Engl. 33 (1994) 1937; b) T. 
Benvegnu, M. Brard, D. Plusquellec, Curr. Opin. Colloid Interface Sci. 8 (2004) 469 
8. a) J. H. Fuhrhop, T. Y. Wang, Chem. Rev. 104 (2004) 2901; b) A. Meister, A. Blume, 
Curr. Opin. Colloid Interface Sci. 12 (2007) 138 
9. a) S. R. Borkar, B. N. Manjunath, B. Sivaraman, I. S. Aidhen, Carbohydr. Res. 358 
(2012) 23; b) P. Hadzic, M. Popsavin, Carbohydr. Res. 345 (2010) 543 
10. a) C. Damez, S. Bouquillon, D. Harakat, F. Hénin, J. Muzart, I. Pezron, L. Komunjer, 
Carbohyd. Res. 342 (2007) 154; b) M. Deleu, C. Damez, S. Gatard, K. Nott, M. Paquot, 
S. Bouquillon, New J. Chem. 35 (2011) 2258; c) M. Deleu, S. Gatard, E. Payen, L. Lins, 
K. Nott, C. Flore, R. Thomas, M. Paquot, S. Bouquillon, C. R. Chim. 15 (2012) 68 
11. F. Brisset, R. Garelli-Calvet, J. Azema, C. Chebli, I. Rico-Lattes, A. Lattes, New J. Chem. 
20 (1996) 595 
12. Z. S. Kovačević, R. L. Jevrić, O. S. Podunavac-Kuzmanović, D. N. Kalajdžija, S. E. 
Lončar, Acta Chim. Slov. 60 (2013) 420 
13. B. Helferich, M. Burgdorf, Tetrahedron 3 (1958) 274 
14. P. Hadžić, N. Vukojević, Carbohydr. Res. 338 (2003) 1243 
15. H. Reiff, D. Dieterich, R. Braden, H. Ziemann, Liebigs Ann. Chem. (1973) 365 
16. P. Hadžić, N. Vukojević, M. Popsavin, J. Čanadi, J. Serb. Chem. Soc. 66 (2001) 1 
17.  a) R. V. Kalla, E. Elzein, T. Perry, X. Li, V. Palle, V. Varkhedkar, A. Gimbel, T. Maa, 
D. Zeng, J. Zablocki, J. Med. Chem. 49 (2006) 3682; b) R.-Y. Lin, B.-N. Wu, Y.-C. Lo, 
L.-M. An, Z.-K. Dai, Y.-T. Lin, C.-S. Tang, I.-J. Chen, Pharmacol. Exp. Ther. 316 (2006) 
709; c) K. Ito, S. Lim, G. Caramori, B. Cosio, K. F. Chung, I. M. Adcock, P. J. Barnes, 
Proc. Natl. Acad. Sci. USA. A 99 (2002) 8921 
18. A. P. Ijzerman, E. M. van der Venden, J. K. von Frijtag Drabbe Kűnzel, R. A. A. Mathôt, 
M. Danhof, P. A. Boreal, K. Varani, Arch. Pharmacol. 350 (1994) 638 
19. a) R. V. Kalla, E. Elzein, T. Perry, X. Li, V. Palle, M. A. N. Mosselhi, Nucleosides 
Nucleotides 12 (1993) 432; b) Z. Wang, Z. Chen, J. Sun, Org. Biomol. Chem. 12 (2014) 6028 
20. a) P. A. Levene, H. Sobotka, J. Biol. Chem. 65 (1925) 463; b) J. Pryde, T. R. Williams, J. 
Chem. Soc. (1933) 640 
21. D. B. Ishay, J. Chem. Soc. (1956) 3975. 
_________________________________________________________________________________________________________________________
(CC) 2015 SCS. All rights reserved.
Available on line at www.shd.org.rs/JSCS/
